Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Oct 2021 for Strongbridge Biopharma plc. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Marten Steen: trading record in brief
Marten Steen (board member) discloses dealings in Strongbridge Biopharma plc to SEC (Form 4). The record holds 4 filings, for trades running from 14 May 2021 to 5 October 2021.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 6 October 2021, the filings show a transaction in Strongbridge Biopharma plc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Marten Steen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
64,151 sharesOrdinary SharesSEC:0001179110-21-009280:0
17,763 shares@ US$2.0646.1% of flowOrdinary SharesSEC:0001179110-21-009226:0
40,000 shares0Ordinary SharesSEC:0001179110-21-005558:0
19,004 shares@ US$2.3553.9% of flowOrdinary SharesSEC:0001179110-21-005553:0
4 of 4 declarations
